Oncology
CAR-TCR 2023 – Becky Cap
In an industry growing as quickly as cell therapy, keeping up with the demands of manufacturing and treatment is a challenge for the whole industry to tackle together, including stakeholder
Oncology
CAR-TCR 2023 – Jason Noon
If we learned anything at CAR-TCR it’s that CAR-T therapies are still a relatively new treatment modality and innovation is happening along many different axes.
Oncology
CAR-TCR 2023 – Greg Deener
In late August, pharmaphorum traveled to Boston to cover CAR-TCR, a conference dedicated to the fast-moving cell therapy space.
Digital
Health Innovators – Or Shoval and Shahar Shelly
Why do the same medications work well in some patients and poorly in others? One reason might be the poorly understood connection between mind and body.
Oncology
Health Innovators – Dr Jack Hoppin and Dr John Babich (follo...
The last time we checked in on Ratio Therapeutics co-founders Dr Jack Hoppin and Dr John Babich, they were working out of a WeWork co-working space in downtown Boston, just beginning their
Editor's Picks
Editor's Picks
